5 Best Heal Care Stocks To Watch Right Now

Celestica (NYSE: CLS  ) reported earnings on April 23. Here are the numbers you need to know.

The 10-second takeaway
For the quarter ended March 31 (Q1), Celestica met expectations on revenues and beat expectations on earnings per share.

Compared to the prior-year quarter, revenue contracted significantly. Non-GAAP earnings per share dropped significantly. GAAP earnings per share dropped significantly.

Margins shrank across the board.

Revenue details
Celestica notched revenue of $1.37 billion. The 11 analysts polled by S&P Capital IQ foresaw revenue of $1.38 billion on the same basis. GAAP reported sales were 19% lower than the prior-year quarter's $1.69 billion.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
EPS came in at $0.16. The 12 earnings estimates compiled by S&P Capital IQ predicted $0.15 per share. Non-GAAP EPS of $0.16 for Q1 were 36% lower than the prior-year quarter's $0.25 per share. GAAP EPS of $0.06 for Q1 were 70% lower than the prior-year quarter's $0.20 per share.

5 Best Heal Care Stocks To Watch Right Now: Danieli(DANI.MI)

Danieli & C. Officine Meccaniche S.p.A. engages in the design, construction, and sale of machinery and plant for the iron and steel industry worldwide. The company?s product lines include turn-key plants and plant engineering; pelletizing and direct reduction; steelworks and casting machines; hot and cold rolling for strip, continuous casting, and process lines; rolling mills and finishing plants for long products; equipment and lines for process, plant, and machinery automation; and electromagnetic systems and induction reheating systems. It also provides reheating and heat treatment furnaces; furnaces for process lines; extrusion presses; non-ferrous rolling products; secondary processing, grinding, drawing, straightening, and peeling machines; and seamless and welded tube production plant; site management; cranes for ports and industrial plants; and scrap shredders, as well as installation, start-up, after-sales service, and spare parts. In addition, the company is inv olved in the production and sale of special steels comprising ingots, blooms, and rolled and forged products. Danieli & C. Officine Meccaniche S.p.A. was formerly known as Angelini Steelworks. The company was founded in 1914 and is headquartered in Buttrio, Italy. Danieli & C. Officine Meccaniche S.p.A. operates as a subsidiary of Sind International S.p.A.

5 Best Heal Care Stocks To Watch Right Now: Novavax Inc.(NVAX)

Novavax, Inc., a clinical-stage biopharmaceutical company, focuses on developing recombinant vaccines for infectious diseases using its virus-like particle platform (VLP) technology. It develops vaccine product candidates that target pandemic influenza, including H1N1 and H5N1 strains; seasonal influenza; and respiratory syncytial virus (RSV). Novavax has a joint venture with Cadila Pharmaceuticals Ltd. to develop and manufacture the company?s pandemic and seasonal influenza vaccine candidates, Cadila?s biogeneric products, and other diagnostic products for the territory of India; and a licensing agreement with LG Life Sciences, Ltd. to use the company?s VLP technology to develop and sell the company?s influenza vaccines in South Korea and other countries. It also has a co-marketing agreement with GE Healthcare for a pandemic influenza vaccine solution. The company was founded in 1987 and is headquartered in Rockville, Maryland.

Advisors' Opinion:

• [By John McCamant]

  Novavax (NVAX) released its Phase I trial of 284 subjects injected with the H7N9 flu virus vaccine.

  While the data was expected to be released before the end of the year, the fact that the NEJM published the Phase I study adds tremendous validation to the NVAX vaccine. We would note that the prestigious NEJM rarely publishes Phase I data.

• [By Roberto Pedone]

  Novavax (NVAX) is a clinical-stage biopharmaceutical company focused on developing recombinant protein nanoparticle vaccines to address a range of infectious diseases. This stock closed up 3.1% to $2.59 in Tuesday's trading session.

  Tuesday's Range: $2.47-$2.63
  
  52-Week Range: $1.52-$2.77
  
  Thursday's Volume: 1.37 million
  
  Three-Month Average Volume: 1.53 million

  From a technical perspective, NVAX spiked notably higher here right above some near-term support at $2.35 with decent upside volume. This move is quickly pushing shares of NVAX within range of triggering a major breakout trade. That trade will hit if NVAX manages to take out some near-term overhead resistance levels at $2.69 to $2.72 and then once it clears its 52-week high at $2.77 with high volume.

  Traders should now look for long-biased trades in NVAX as long as it's trending above some near-term support at $2.35 or its 50-day at $2.19 and then once it sustains a move or close above those breakout levels with volume that hits near or above 1.53 million shares. If that breakout triggers soon, then NVAX will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that breakout are $3.50 to $4.

• [By Jay Silverman]

  Jay Silverman: Well, one of the areas that I didn't mention in your last question was vaccines, and we've had the beginnings of success with our Novavax (NVAX) recommendation. I can't say it's going to be the Top Pick for 2014, because we haven't really discussed that and agreed upon those names yet.

• [By Roberto Pedone]

  Another under-$10 biotechnology player that's starting to trend within range of triggering a major breakout trade is Novavax (NVAX), a clinical-stage biopharmaceutical company focused on developing recombinant protein nanoparticle vaccines to address a range of infectious diseases. This stock has been a monster for the bulls so far in 2013, with shares up a whopping 445%.

  If you take a look at the chart for Novavax, you'll notice that this stock has been uptrending for the last few weeks, with shares moving higher from its low of $2.68 to its intraday high of $3.27 a share. During that move, shares of NVAX have been consistently making higher lows and higher highs, which is bullish technical price action. That move is quickly pushing shares of NVAX within range of triggering a major breakout trade.

  Market players should now look for long-biased trades in NVAX if it manages to break out above some near-term overhead resistance levels at $3.39 a share to its 52-week high at $3.50 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 3 million shares. If that breakout triggers soon, then NVAX will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that breakout are $5 to $6 a share.

  Traders can look to buy NVAX off weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support levels at $3 to $2.68 a share. One can also buy NVAX off strength once it clears those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

Top 5 Bank Stocks To Buy Right Now: eFuture Information Technology Inc.(EFUT)

eFuture Information Technology Inc. provides integrated software and services to retail and consumer goods industries in the People?s Republic of China. It offers software solutions, which include foundation solutions for retail management, point of sale, distribution management, logistics management, warehouse management, vendor payment and control, and loyalty card management; collaborative solutions for visual SCM and visual process management systems; and intelligent solutions for business intelligence, brand analysis, supplier relationship management, and customer relationship management systems. The company also provides support services on existing software installations; delivery services; consulting services, including systems planning and design, customer-specific configuration of application modules, and onsite implementation or conversion from existing systems; post-implementation consulting services, such as utilization reviews and business process optimizati on; and outsourcing services comprising design, development, implementation, operation, and continuous improvement of information technology and business functions. In addition, it offers cloud services based on cloud computing architecture, such as B2C eCommerce and salesforce automation. The company serves manufacturers, distributors, wholesalers, logistics companies, and retailers in front-end supply chain market. It has strategic partnerships with Microsoft Corporation and JDA Software Group, Inc. to co-develop software and to implement partners? solutions. The company was formerly known as e-Future Information Technology Inc. and changed its name to eFuture Information Technology Inc. in 2008. eFuture Information Technology Inc. was founded in 1997 and is headquartered in Beijing, the People?s Republic of China.

5 Best Heal Care Stocks To Watch Right Now: M&T Bank Corporation (MTB)

M&T Bank Corporation operates as the holding company for M&T Bank and M&T Bank, National Association that provide commercial and retail banking services to individuals, corporations and other businesses, and institutions. It offers business loans and leases; business credit cards; deposit products, such as demand, savings, and time accounts; and financial services, including cash management, payroll and direct deposit, merchant credit card, and letters of credit. The company also provides residential real estate loans; multifamily commercial real estate loans; commercial real estate loans; one-to-four family residential mortgage loans; investment and trading securities; short-term and long-term borrowed funds; brokered certificates of deposit and interest rate swap agreements related thereto; and branch deposits. In addition, it offers foreign exchange, as well as asset management services. Further, the company provides consumer loans, and commercial loans and leases; cred it life, and accident and health reinsurance; and securities brokerage, investment advisory, and insurance agency services. As of December 31, 2009, it had 738 banking offices in New York State, Pennsylvania, Maryland, Delaware, New Jersey, Virginia, West Virginia, and the District of Columbia; a commercial banking office in Ontario, Canada; and an office in George Town, Cayman Islands. The company was founded in 1969 and is headquartered in Buffalo, New York.

Advisors' Opinion:

• [By Matt Koppenheffer]

  At�Berkshire Hathaway� (NYSE: BRK-A  ) (NYSE: BRK-B  ) Buffett has a portfolio that's top-heavy with financial-industry exposure, and he's particularly overweight in large-cap banks.�Wells Fargo� (NYSE: WFC  ) is the conglomerate's single largest common-stock holding at close to $20 billion. The company also holds a $2 billion-plus position in�U.S. Bancorp� (NYSE: USB  ) . Combined positions in�Bank of New York Mellon� (NYSE: BK  ) and�M&T Bank� (NYSE: MTB  ) come out to more than $1 billion. Berkshire will also have a large common-stock position in�Goldman Sachs� (NYSE: GS  ) when the companies settle up Berkshire's warrants later this year. Based on today's share price for Goldman, that stake would likely be over $2 billion. Finally, the company has a $5 billion preferred-stock investment in�Bank of America� (NYSE: BAC  ) .

5 Best Heal Care Stocks To Watch Right Now: New Dimension Resources Ltd. (NDR.V)

New Dimension Resources Ltd. engages in the acquisition, exploration, and development of mineral resource properties in the Americas. It primarily explores for gold and silver deposits. The company principally focuses on the exploration of Cenepa gold project in Cordillera del Condor mineral belt in northern Peru and southern Ecuador. New Dimension Resources Ltd. was incorporated in 2005 and is based in Vancouver, Canada.